Urology - Market - Report - Suite - Europe - 2022-2028 - MedSuite

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $8,995	602 Pages	iData Research, Inc.	February, 2022	IDR17686857

Best Price Guarantee
Price	from $8,995
Length	602 Pages
Publisher	iData Research, Inc.
Published Date	February, 2022
SKU	IDR17686857

Urology - Market - Report - Suite - Europe - 2022-2028 - MedSuite

Overall, Europe’s urological device market was valued at €1.7 billion in 2021. This was a 10% decrease from the 2020 market value with the global COVID-19 pandemic having an impact on the market. However, this is expected to increase over the forecasted period at a CAGR of 2.6% to reach €2.1 billion by 2028.

Currently, the strongest competitors within Europe’s urological device market are Coloplast and Wellspect Healthcare alongside other market leaders such as Becton Dickinson, Hollister Inc. and Boston Scientific.

Throughout this medical market research, we analyzed over 60 urological device companies in Europe and around the world using our comprehensive methodology to understand the market sizes, unit sales, company market shares, procedure volumes, and to create accurate forecasts.

MARKET DATA INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2028, and Historical Data to 2018
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
EUROPE UROLOGICAL DEVICE MARKET INSIGHTS
Urological devices

Overall, the urological device market is strongly established. This limits the potential for substantial growth. Although companies continue to provide novel adaptations for their products, the general trend within most segments of the market is a fairly flat ASP. Furthermore, the ASP has been limited by the lack of reimbursement in some countries along with price pressures witnessed across Europe.

EUROPE UROLOGICAL DEVICE MARKET SHARE INSIGHTS

The European urological device market was controlled by Coloplast and Wellspect Healthcare. In 2021, the leading competitor in the urological device market was Coloplast. The company held the top position in the urinary catheter, urinary guidewire and erectile dysfunction device segments. It also played a substantial role in the stone management device, nephrostomy device and urinary incontinence device segments.

MARKET SEGMENTATION SUMMARY

Urinary Catheter Market – Further Segmented Into:
Intermittent, Foley, male external catheters (MECs) and female external catheters (FECs).
Urinary Incontinence Device Market – Further Segmented Into:
UBAs and incontinence slings.
BPH Treatment Device Market — Further Segmented Into:
Devices used for transurethral resection of the prostate (TURP), laser BPH, UroLift® and Rez?m® procedures.
Urological Endoscope Market — Further Segmented Into:
Single-use, rigid and flexible cystoscopes, single-use, semi-rigid and flexible ureteroscopes, rigid resectoscopes and rigid nephroscopes.
Low-Dose Radiation Brachy Therapy Device Market — Further Segmented Into:
LDR seeds.
Nephrostemy Market — Further Segmented Into:
Percutaneous nephrostomy sets, nephrostomy balloon dilators and nephrostomy drainage tubes.
Erectile Dysfunction Device Market — Further Segmented Into:
Inflatable erectile dysfunction devices and malleable erectile dysfunction devices.
Urinary Guidewire Market — Further Segmented Into:
All guidewires to be used in urological procedures.
Stone Management Device Market – Further Segmented Into:
ESWL capital equipment, laser equipment, stone fragment retrieval devices, ureteral stents and access sheaths.

RESEARCH SCOPE SUMMARY

Region: Europe
Base Year: 2021
Forecast: 2022 – 2028
Historical Data: 2018 – 2021
Quantitative Coverage: Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices
Qualitative Coverage: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. WHY CHOOSE iDATA?
Experts Only – iData has been around for over 16 years and is the trusted source of intelligent, data-driven insights by key industry players. We are comprised of specialists with a sole focus on medical and dental devices. Our research and consulting focus never strays from the medical device industry and, because of this, we know the industry like the back of our hands.

Attention to Details - It’s our attention to the small stuff, scheduling of timelines and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing - Our prices are competitive and fair. We strive for success and want our clients to as well, with the level of detail our reports achieve along with the extensive segmentation, no other reports compare at our price point.

Work with us, and you’ll work with seasoned professionals – vigilant of deadlines, and committed to providing the most up-to-date, accurate medical device market research.

The full report suite on the European Urological Devices Market includes coverage on the Urinary Catheter Market, Urinary Incontinence Device Market, BPH Treatment Device Market, Urological Endoscope Makret, Low-Dose Radiation Brachy Therapy Device Market, Nephrostemy Market, Erectile Dysfunction Device Market, Urinary Guidewire Market, and Stone Management Device Market.

EXECUTIVE SUMMARY
EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW: COMPETITIVE ANALYSIS; MARKET TRENDS; MARKET DEVELOPMENTS; PROCEDURE NUMBERS; MARKETS INCLUDED; KEY REPORT UPDATES; VERSION HISTORY; RESEARCH METHODOLOGY
IMPACT OF COVID-19 ON THE EUROPEAN UROLOGICAL DEVICE MARKET: 2.1 INTRODUCTION; 2.2 COUNTRY PROFILES; 2.3 ANALYSIS BY MARKET SEGMENT
DISEASE OVERVIEW: 3.1 BASIC ANATOMY; 3.2 DISEASE TREATMENT AND DIAGNOSTICS; 3.3 PATIENT DEMOGRAPHICS
PRODUCT ASSESSMENT: 4.1 INTRODUCTION; 4.2 PRODUCT PORTFOLIOS; 4.3 REGULATORY ISSUES AND RECALLS; 4.4 CLINICAL TRIALS
EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW: 5.1 CURRENCY EXCHANGE RATE; 5.2 MARKET OVERVIEW & TREND ANALYSIS; 5.3 DRIVERS AND LIMITERS; 5.4 COMPETITIVE MARKET SHARE ANALYSIS; 5.5 MERGERS AND ACQUISITIONS; 5.6 COMPANY PROFILES; 5.7 SWOT ANALYSIS
COUNTRY PROFILES: 6.1 INTRODUCTION; 6.2 GERMANY; 6.3 FRANCE; 6.4 UNITED KINGDOM; 6.5 ITALY; 6.6 SPAIN; 6.7 BENELUX; 6.8 SCANDINAVIA; 6.9 AUSTRIA; 6.10 SWITZERLAND; 6.11 PORTUGAL
PROCEDURE NUMBERS: 7.1 PROCEDURE OVERVIEW; 7.2 PROSTATE CANCER TREATMENT PROCEDURES; 7.3 INTERVENTIONAL BPH PROCEDURES; 7.4 STONE MANAGEMENT PROCEDURES; 7.5 NEPHROSTOMY PROCEDURES; 7.6 URINARY INCONTINENCE PROCEDURES; 7.7 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES
URINARY CATHETER MARKET: 8.1 INTRODUCTION; 8.2 MARKET OVERVIEW; 8.3 MARKET ANALYSIS AND FORECAST; 8.4 DRIVERS AND LIMITERS; 8.5 COMPETITIVE MARKET SHARE ANALYSIS
URINARY INCONTINENCE DEVICE MARKET: 9.1 INTRODUCTION; 9.2 MARKET OVERVIEW; 9.3 MARKET ANALYSIS AND FORECAST; 9.4 DRIVERS AND LIMITERS; 9.5 COMPETITIVE MARKET SHARE ANALYSIS
STONE MANAGEMENT DEVICE MARKET: 10.1 INTRODUCTION; 10.2 MARKET OVERVIEW; 10.3 MARKET ANALYSIS AND FORECAST; 10.4 DRIVERS AND LIMITERS; 10.5 COMPETITIVE MARKET SHARE ANALYSIS
BPH TREATMENT DEVICE MARKET: 11.1 INTRODUCTION; 11.2 MARKET OVERVIEW; 11.3 MARKET ANALYSIS AND FORECAST; 11.4 DRIVERS AND LIMITERS; 11.5 COMPETITIVE MARKET SHARE ANALYSIS
UROLOGICAL ENDOSCOPE MARKET: 12.1 INTRODUCTION; 12.2 MARKET OVERVIEW; 12.3 MARKET ANALYSIS AND FORECAST; 12.4 DRIVERS AND LIMITERS; 12.5 COMPETITIVE MARKET SHARE ANALYSIS
LOW DOSE RADIATION BRACHYTHERAPY DEVICE MARKET: 13.1 INTRODUCTION; 13.2 MARKET ANALYSIS AND FORECAST; 13.3 DRIVERS AND LIMITERS; 13.4 COMPETITIVE MARKET SHARE ANALYSIS
NEPHROSTOMY DEVICE MARKET: 14.1 INTRODUCTION; 14.2 MARKET OVERVIEW; 14.3 MARKET ANALYSIS AND FORECAST; 14.4 DRIVERS AND LIMITERS; 14.5 COMPETITIVE MARKET SHARE ANALYSIS
ERECTILE DYSFUNCTION DEVICE MARKET: 15.1 INTRODUCTION; 15.2 MARKET OVERVIEW; 15.3 MARKET ANALYSIS AND FORECAST; 15.4 DRIVERS AND LIMITERS; 15.5 COMPETITIVE MARKET SHARE ANALYSIS
URINARY GUIDEWIRE MARKET: 16.1 INTRODUCTION; 16.2 MARKET ANALYSIS AND FORECAST; 16.3 DRIVERS AND LIMITERS; 16.4 COMPETITIVE MARKET SHARE ANALYSIS; ABBREVIATIONS
LIST OF CHARTS: Chart 1 1: Urological Device Market by Segment, Europe, 2021 – 2028; Chart 1 2: Urological Device Market Overview, Europe, 2021 & 2028; Chart 2 1: Multi-Scenario Urological Device Market Forecast, Europe, 2018 – 2028 (€M); Chart 5 1: Urological Device Market by Segment, Europe, 2018 – 2028; Chart 5 2: Leading Competitors, Urological Device Market, Europe, 2021; Chart 6 1: Country Profile, Germany, 2021; Chart 6 2: Country Profile, France, 2021; Chart 6 3: Country Profile, United Kingdom, 2021; Chart 6 4: Country Profile, Italy, 2021; Chart 6 5: Country Profile, Spain, 2021; Chart 6 6: Country Profile, Benelux, 2021; Chart 6 7: Country Profile, Scandinavia, 2021; Chart 6 8: Country Profile, Austria, 2021; Chart 6 9: Country Profile, Switzerland, 2021; Chart 6 10: Country Profile, Portugal, 2021; Chart 7 1: Urological Procedures by Segment, Europe, 2018 – 2028; Chart 8 1: Leading Competitors, Urinary Catheter Market, Europe, 2021; Chart 9 1: Urinary Incontinence Device Market by Segment, Europe, 2018 – 2028; Chart 9 2: Leading Competitors, Urinary Incontinence Device Market, Europe, 2021; Chart 10 1: Stone Management Device Market by Segment, Europe, 2018 – 2028; Chart 10 2: Leading Competitors, Stone Management Device Market, Europe, 2021; Chart 11 1: BPH Treatment Device Market by Segment, Europe, 2018 – 2028; Chart 11 2: Leading Competitors, BPH Treatment Device Market, Europe, 2021; Chart 12 1: Urological Endoscope Market by Segment, Europe, 2018 – 2028; Chart 12 2: Leading Competitors, Urological Endoscope Market, Europe, 2021; Chart 13 1: LDR Brachytherapy Market, Europe, 2018 – 2028; Chart 13 2: Leading Competitors, Lose Dose Radiation Brachytherapy Device Market, Europe, 2021; Chart 14 1: Nephrostomy Device Market by Segment, Europe, 2018 – 2028; Chart 14 2: Leading Competitors, Nephrostomy Device Market, Europe, 2021; Chart 15 1: Erectile Dysfunction Device Market by Segment, Europe, 2018 – 2028; Chart 15 2: Leading Competitors, Erectile Dysfunction Device Market, Europe, 2021; Chart 16 1: Urinary Guidewire Market, Europe, 2018 – 2028; Chart 16 2: Leading Competitors, Urinary Guidewire Market, Europe, 2021
List of Figures: Figure 1-1: Urological Device Market Share Ranking by Segment, Europe, 2021 (1 of 2) 4; Figure 1-2: Urological Device Market Share Ranking by Segment, Europe, 2021 (2 of 2) 5; Figure 1-3: Companies Researched in this Report (1 of 2) 6; Figure 1-4: Companies Researched in this Report (2 of 2) 7; Figure 1-5: Factors Impacting the Urological Device Market by Segment, Europe (1 of 2) 8; Figure 1-6: Factors Impacting the Urological Device Market by Segment, Europe (2 of 2) 9; Figure 1-7: Recent Events in the Urological Device Market, Europe, 2018 – 2022 10; Figure 1-8: Urological Device Procedures Covered, Europe 11; Figure 1-9: Urological Device Markets Covered, Europe (1 of 2) 12; Figure 1-10: Urological Device Markets Covered, Europe (2 of 2) 13; Figure 1-11: Key Report Updates 14; Figure 1-12: Version History 14; Figure 2-1: Urological Device Market by Segment, Worst Case Scenario, Europe, 2018 – 2028 (€M) (1 of 2) 36; Figure 2-2: Urological Device Market by Segment, Worst Case Scenario, Europe, 2018 – 2028 (€M) (2 of 2) 37; Figure 2-3: Urological Device Market by Segment, Base Case Scenario, Europe, 2018 – 2028 (€M) (1 of 2) 38; Figure 2-4: Urological Device Market by Segment, Base Case Scenario, Europe, 2018 – 2028 (€M) (2 of 2) 39; Figure 2-5: Urological Device Market by Segment, Best Case Scenario, Europe, 2018 – 2028 (€M) (1 of 2) 40; Figure 2- 6: Urological Device Market by Segment, Best Case Scenario, Europe, 2018 – 2028 (€M) (2 of 2) 41; Figure 4-1: Urinary Incontinence Treatments by Company (1 of 3) 75; Figure 4-2: Urinary Incontinence Treatments by Company (2 of 3) 76; Figure 4-3: Urinary Incontinence Treatments by Company (3 of 3) 77; Figure 4-4: Stone Management Devices by Company (1 of 3) 82; Figure 4-5: Stone Management Devices by Company (2 of 3) 83; Figure 4-6: Stone Management Devices by Company (3 of 3) 84; Figure 4-7: BPH Treatments by Company 94; Figure 4-8: Urological Endoscopes by Company (1 of 2) 98; Figure 4-9: Urological Endoscopes by Company (2 of 2) 99; Figure 4-10: Prostate Cancer Treatments by Company 103; Figure 4-11: Urodynamic Equipment and Consumables by Company 107; Figure 4-12: Nephrostomy Devices by Company 110; Figure 4-13: Men’s Reproductive Health Devices by Company 113; Figure 4-14: Testicular Implants by Company 114; Figure 4-15: Urinary Guidewires by Company 115; Figure 4-16: Class 2 Device Recall Magic 3 Intermittent Catheters 116; Figure 4-17: Class 2 Device Recall Bardex Lubricath 3Way 75cc Continuous Irrigation Foley Catheter 116; Figure 4-18: Class 2 Device Recall Bard Magic 3 Antibacterial Hydrophilic Intermittent Catheter 116; Figure 4-19: Class 2 Device Recall SureStep 117; Figure 4-20: Class 2 Device Recall AMS 800 Artificial Urinary Sphincter AMS 800 Belt Cuff 117; Figure 4-21: Class 2 Device Recall AMS 700 100 mL Spherical Reservoir with InhibiZone 117; Figure 4-22: Class 2 Device Recall Uphold LITE w/ Capio SLIM 118; Figure 4-23: Class 2 Device Recall Stretch VL Ureteral Stent Set 118; Figure 4-24: Class 2 Device Recall Contour VL Ureteral Stent Set 118; Figure 4-25: Class 2 Device Recall Auriga 30 Laser System 119; Figure 4-26: Class 2 Device Recall AURIGA 30 BRAZIL ZERO COST SYSTEM 119; Figure 4-27: Class 2 Device Recall MoXy Laser Fiber 119; Figure 4-28: Class 2 Device Recall IcePearl 2.1 CX 90 Cyroablation Needles 120; Figure 4-29: Class 2 Device Recall IceSphere Cryoablation Needles 120; Figure 4-30: Class 2 Device Recall Titan Pump 121; Figure 4-31: Class 2 Device Recall Dornier 121; Figure 4-32: Class 2 Device Recall Visual ICE Cryoablation System 122; Figure 4-33: Class 2 Device Recall Ureteroreno videoscope URFV2; Ureteroreno videoscope URFV2R 123; Figure 4-34: Class 3 Device Recall RUSCH Urinary Drainage bag 123; Figure 4-35: Class 2 Device Recall Rusch EasyCath Kit 124; Figure 4-36: Class 3 Device Recall Teleflex MEDICAL RuSCH One piece Male External Medium Catheter W/O Tape 124; Figure 4-37: Artificial Urinary Sphincter Clinical Outcomes (AUSCO) 125; Figure 4-38: Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy (SASS) 125; Figure 4-39: Double-J PLUS Postmarket Registry 126; Figure 4-40: Rezum I Pilot Study for Benign Prostatic Hyperplasia (Rezum Pilot) 126; Figure 4-41: Rezum FIM Optimization Study (Rezum FIM) 127; Figure 4-42: To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China 127; Figure 4-43: To Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients With Urinary Disease (LithoVue) 128; Figure 4-44: Investigation of New Intermittent Catheters in Healthy Volunteers 128; Figure 4-45: Exploratory Study of a New Urine Collection Device for Men 129; Figure 4-46: Investigation of Non-CE Marked Intermittent Catheters for Females 129; Figure 4-47: T-DOC® 5 Fr Pediatric Clinical Investigation 130; Figure 4-48: T-DOC® NXT Clinical Investigation 130; Figure 4-49: e۰Sense® Catheter Clinical Investigation 131; Figure 4-50: T-DOC® 5 Fr Pediatric Clinical Investigation 131; Figure 4-51: Study of Median Lobe Prostatic UroLift Procedure 132; Figure 4-52: Urodynamic Feasibility Study Utilizing the UroLift® System (UDS) 132; Figure 4-53: Comparing UroLift Experience Against Rezūm (CLEAR) 133; Figure 4-54: ARTUS MONO Artificial Urinary Sphincter 133; Figure 4-55: Safety and Efficacy Study of USTRAP™ in Male Urinary Incontinence (PROSPECT) 134; Figure 4-56: Connected Catheter- Safety and Effectiveness Study 134; Figure 4-57: Evaluation of a New Female Urinary Intermittent Catheter 135; Figure 4-58: Post-Market Clinical Follow-Up onTVT EXACT® Continence System 135; Figure 4-59: A Study of the PedSCath Pediatric Sampling Catheter Versus Current Standard of Care. 136; Figure 4-60: Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy (URIPRENE) 136; Figure 4-61: The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position 137; Figure 4-62: Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder 137; Figure 4-63: Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy 138; Figure 4-64: LDR vs. HDR Brachytherapy for Prostate Cancer (LDR/HDRmono) 138; Figure 4-65: Urodynamic Assessment of the Lower Urinary Tract: Water vs. Air - Synchrony 139; Figure 5-1: Currency Exchange Rate, 2021 140; Figure 5-2: Urological Device Market by Segment, Europe, 2018 – 2028 (€M) (1 of 2) 143; Figure 5-3: Urological Device Market by Segment, Europe, 2018 – 2028 (€M) (2 of 2) 144; Figure 5-4: Urological Device Market by Segment, Europe, 2018 – 2028 (US$M) (1 of 2) 145; Figure 5-5: Urological Device Market by Segment, Europe, 2018 – 2028 (US$M) (2 of 2) 146; Figure 5-6: Leading Competitors, Urological Device Market, Europe, 2021 (1 of 2) 155; Figure 5-7: Leading Competitors, Urological Device Market, Europe, 2021 (1 of 2) 156; Figure 5-8: Others Include: 157; Figure 5-9: SWOT Analysis, Becton Dickinson 174; Figure 5-10: SWOT Analysis, Boston Scientific 175; Figure 5-11: SWOT Analysis, Cardinal Health 176; Figure 5-12: SWOT Analysis, Coloplast 177; Figure 5-13: SWOT Analysis, Cook Medical 178; Figure 5-14: SWOT Analysis, Elekta 179; Figure 5-15: SWOT Analysis, Karl Storz 180; Figure 5-16: SWOT Analysis, LABORIE 181; Figure 5-17: SWOT Analysis, Lumenis 182; Figure 5-18: SWOT Analysis, Olympus 183; Figure 5-19: SWOT Analysis, Teleflex 184; Figure 7-1: Urological Procedures by Segment, Europe, 2018 – 2028 197; Figure 7-2: Urological Procedures by Country, Europe, 2018 – 2028 198; Figure 7-3: Prostate Cancer Procedures by Type, Europe, 2018 – 2028 (1 of 2) 201; Figure 7-4: Prostate Cancer Procedures by Type, Europe, 2018 – 2028 (2 of 2) 202; Figure 7-5: Total Prostate Cancer Procedures by Country, Europe, 2018 – 2028 203; Figure 7-6: Open and Laparoscopic Prostatectomy Procedures by Country, Europe, 2018 – 2028 204; Figure 7-7: Robotic Prostatectomy Procedures by Country, Europe, 2018 – 2028 205; Figure 7-8: Watchful Waiting Procedures by Country, Europe, 2018 – 2028 206; Figure 7-9: HIFU Procedures by Country, Europe, 2018 – 2028 207; Figure 7-10: Brachytherapy Procedures by Country, Europe, 2018 – 2028 208; Figure 7-11: High Dose Radiation Procedures by Country, Europe, 2018 – 2028 209; Figure 7-12: External Radiation Therapy (Primary) Procedures by Country, Europe, 2018 – 2028 210; Figure 7-13: External Radiation Therapy (Secondary) Procedures by Country, Europe, 2018 – 2028 211; Figure 7-14: Interventional BPH Procedures by Type, Europe, 2018 – 2028yeah no 213; Figure 7-15: Total Interventional BPH Procedures by Country, Europe, 2018 – 2028 214; Figure 7-16: TURP Procedures by Country, Europe, 2018 – 2028 215; Figure 7-17: Laser BPH Procedures by Country, Europe, 2018 – 2028 216; Figure 7-18: Stone Management Procedures by Type, Europe, 2015 – 2025 218; Figure 7-19: Total Stone Management Procedures by Country, Europe, 2018 – 2028 219; Figure 7-20: ESWL Procedures by Country, Europe, 2018 – 2028 220; Figure 7-21: Stone Management Holmium Laser Procedures by Country, Europe, 2018 – 2028 221; Figure 7-22: PCNL Procedures by Country, Europe, 2018 – 2028 222; Figure 7-23: Ureteral Stent Placement Procedures by Country, Europe, 2018 – 2028 223; Figure 7-24: Nephrostomy Procedures by Country, Europe, 2018 – 2028 225; Figure 7-25: Urinary Incontinence Procedures by Type, Europe, 2018 – 2028 227; Figure 7-26: Total Urinary Incontinence Procedures by Country, Europe, 2018 – 2028 228; Figure 7-27: Male Urinary Incontinence Procedures by Country, Europe, 2018 – 2028 229; Figure 7-28: Female Urinary Incontinence Procedures by Country, Europe, 2018 – 2028 230; Figure 7-29: Erectile Dysfunction Procedures by Country, Europe, 2018 – 2028 232; Figure 7-30: Inflatable Implant Procedures by Country, Europe, 2018 – 2028 233; Figure 7-31: Malleable Implant Procedures by Country, Europe, 2018 – 2028 234; Figure 8-1: Urinary Catheter Market by Segment, Europe, 2018 – 2028 (€M) 237; Figure 8-2: Urinary Catheter Market by Segment, Europe, 2018 – 2028 (US$M) 238; Figure 8-3: Total Urinary Catheter Market, Europe, 2018 – 2028 240; Figure 8-4: Units Sold by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (1 of 2) 241; Figure 8-5: Units Sold by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (2 of 2) 242; Figure 8-6: Average Selling Price by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (€) 243; Figure 8-7: Average Selling Price by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (US$) 244; Figure 8-8: Market Value by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (€M) 245; Figure 8-9: Market Value by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (US$M) 246; Figure 8-10: Intermittent Catheter Market, Europe, 2018 – 2028 248; Figure 8-11: Units Sold by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (1 of 2) 249; Figure 8-12: Units Sold by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (2 of 2) 250; Figure 8-13: Average Selling Price by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (€) 251; Figure 8-14: Average Selling Price by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (US$) 252; Figure 8-15: Market Value by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (€M) 253; Figure 8-16: Market Value by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (US$M) 254; Figure 8-17: Foley Catheter Market, Europe, 2018 – 2028 256; Figure 8-18: Units Sold by Country, Foley Catheter Market, Europe, 2018 – 2028 (1 of 2) 257; Figure 8-19: Units Sold by Country, Foley Catheter Market, Europe, 2018 – 2028 (2 of 2) 258; Figure 8-20: Average Selling Price by Country, Foley Catheter Market, Europe, 2018 – 2028 (€) 259; Figure 8-21: Average Selling Price by Country, Foley Catheter Market, Europe, 2018 – 2028 (US$) 260; Figure 8-22: Market Value by Country, Foley Catheter Market, Europe, 2018 – 2028 (€M) 261; Figure 8-23: Market Value by Country, Foley Catheter Market, Europe, 2018 – 2028 (US$M) 262; Figure 8-24: External Catheter Market by Segment, Europe, 2018 – 2028 (€M) 263; Figure 8-25: External Catheter Market by Segment, Europe, 2018 – 2028 (US$M) 264; Figure 8-26: Total External Catheter Market, Europe, 2018 – 2028 265; Figure 8-27: Male External Catheter Market, Europe, 2018 – 2028 267; Figure 8-28: Units Sold by Country, Male External Catheter Market, Europe, 2018 – 2028 268; Figure 8-29: Average Selling Price by Country, Male External Catheter Market, Europe, 2018 – 2028 (€) 269; Figure 8-30: Average Selling Price by Country, Male External Catheter Market, Europe, 2018 – 2028 (US$) 270; Figure 8-31: Market Value by Country, Male External Catheter Market, Europe, 2018 – 2028 (€M) 271; Figure 8-32: Market Value by Country, Male External Catheter Market, Europe, 2018 – 2028 (US$M) 272; Figure 8-33: Female External Catheter Market, Europe, 2018 – 2028 273; Figure 8-34: Leading Competitors, Urinary Catheter Market, Europe, 2021 279; Figure 9-1: Urinary Incontinence Device Market by Segment, Europe, 2018 – 2028 (€M) 284; Figure 9-2: Urinary Incontinence Device Market by Segment, Europe, 2018 – 2028 (US$M) 284; Figure 9-3: Urethral Bulking Agent Market, Europe, 2018 – 2028 287; Figure 9-4: Urinary Incontinence Sling Market by Segment, Europe, 2018 – 2028 (€M) 288; Figure 9-5: Urinary Incontinence Sling Market by Segment, Europe, 2018 – 2028 (US$M) 289; Figure 9-6: Total Urinary Incontinence Sling Market, Europe, 2018 – 2028 290; Figure 9-7: Units Sold by Country, Total Incontinence Management Device Market, Europe, 2018 – 2028 291; Figure 9-8: Average Selling Price by Country, Total Incontinence Management Device Market, Europe, 2018 – 2028 (€) 292; Figure 9-9: Average Selling Price by Country, Total Incontinence Management Device Market, Europe, 2018 – 2028 (US$) 293; Figure 9-10: Market Value by Country, Total Incontinence Management Device Market, Europe, 2018 – 2028 (€M) 294; Figure 9-11: Market Value by Country, Total Incontinence Management Device Market, Europe, 2018 – 2028 (US$M) 295; Figure 9-12: Female Incontinence Sling Market by Segment, Europe, 2018 – 2028 (€M) 297; Figure 9-13: Female Incontinence Sling Market by Segment, Europe, 2018 – 2028 (US$M) 298; Figure 9-14: Total Female Incontinence Sling Market, Europe, 2018 – 2028 299; Figure 9-15: Units Sold by Country, Total Female Incontinence Sling Market, Europe, 2018 – 2028 300; Figure 9-16: Average Selling Price by Country, Total Female Incontinence Sling Market, Europe, 2018 – 2028 (€) 301; Figure 9-17: Average Selling Price by Country, Total Female Incontinence Sling Market, Europe, 2018 – 2028 (US$) 302; Figure 9-18: Market Value by Country, Total Female Incontinence Sling Market, Europe, 2018 – 2028 (€M) 303; Figure 9-19: Market Value by Country, Total Female Incontinence Sling Marke